# A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention

Study · id `cardio:ct-nct01327183` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01327183](<https://clinicaltrials.gov/study/NCT01327183>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01327183

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 532 participants.

## Technical summary

Registry record NCT01327183. Randomized; double masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2012-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 532 participants (enrolled count; ClinicalTrials.gov record NCT01327183, source copy `cardio:ctgov-nct01327183-2016-11-02`, retrieved 2026-10-26)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01327183, source copy `cardio:ctgov-nct01327183-2016-11-02`, retrieved 2026-10-26)
- Primary completion: 2012-10 (actual) (ClinicalTrials.gov record NCT01327183, source copy `cardio:ctgov-nct01327183-2016-11-02`, retrieved 2026-10-26)
- Completion: 2012-10 (actual) (ClinicalTrials.gov record NCT01327183, source copy `cardio:ctgov-nct01327183-2016-11-02`, retrieved 2026-10-26)
- Countries: United States; Canada; Netherlands; Poland (ClinicalTrials.gov record NCT01327183, source copy `cardio:ctgov-nct01327183-2016-11-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01327183-2016-11-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
- Condition: Myocardial Infarction
- Intervention (Procedure): Percutaneous Coronary Intervention (PCI)
- Intervention (Drug): RO4905417
- Intervention (Drug): RO4905417
- Intervention (Drug): placebo
- Lead sponsor: Hoffmann-La Roche
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Hoffmann-La Roche (`cardio:org-hoffmann-la-roche`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial (`cardio:pubmed-23500230`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial (`cardio:pubmed-27852589`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c58f8860f92fe9fc2520e0bd07a710f0d8ebcd3a4f9ef6b5b3b1c2250f9c51d5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
